Seelos Therapeutics Inc (SEEL)
0.3214
+0.02
(+7.38%)
USD |
NASDAQ |
May 02, 16:00
0.3214
0.00 (0.00%)
After-Hours: 20:00
Seelos Therapeutics Max Drawdown (5Y): 99.93% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.93% |
March 31, 2024 | 99.93% |
February 29, 2024 | 99.93% |
January 31, 2024 | 99.93% |
December 31, 2023 | 99.93% |
November 30, 2023 | 99.93% |
October 31, 2023 | 99.93% |
September 30, 2023 | 99.93% |
August 31, 2023 | 99.93% |
July 31, 2023 | 99.93% |
June 30, 2023 | 99.93% |
May 31, 2023 | 99.93% |
April 30, 2023 | 99.93% |
March 31, 2023 | 99.93% |
February 28, 2023 | 99.93% |
January 31, 2023 | 99.93% |
December 31, 2022 | 99.93% |
November 30, 2022 | 99.93% |
October 31, 2022 | 99.93% |
September 30, 2022 | 99.93% |
August 31, 2022 | 99.93% |
July 31, 2022 | 99.93% |
June 30, 2022 | 99.93% |
May 31, 2022 | 99.93% |
April 30, 2022 | 99.93% |
Date | Value |
---|---|
March 31, 2022 | 99.93% |
February 28, 2022 | 99.93% |
January 31, 2022 | 99.93% |
December 31, 2021 | 99.93% |
November 30, 2021 | 99.93% |
October 31, 2021 | 99.93% |
September 30, 2021 | 99.93% |
August 31, 2021 | 99.93% |
July 31, 2021 | 99.93% |
June 30, 2021 | 99.93% |
May 31, 2021 | 99.93% |
April 30, 2021 | 99.93% |
March 31, 2021 | 99.93% |
February 28, 2021 | 99.93% |
January 31, 2021 | 99.93% |
December 31, 2020 | 99.93% |
November 30, 2020 | 99.93% |
October 31, 2020 | 99.93% |
September 30, 2020 | 99.93% |
August 31, 2020 | 99.93% |
July 31, 2020 | 99.93% |
June 30, 2020 | 99.93% |
May 31, 2020 | 99.93% |
April 30, 2020 | 99.93% |
March 31, 2020 | 99.92% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.81%
Minimum
May 2019
99.93%
Maximum
Apr 2020
99.92%
Average
99.93%
Median
Apr 2020
Max Drawdown (5Y) Benchmarks
180 Life Sciences Corp | 99.97% |
Acurx Pharmaceuticals Inc | -- |
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -93.18 |
Beta (5Y) | 2.029 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 128.4% |
Historical Sharpe Ratio (5Y) | -0.5494 |
Historical Sortino (5Y) | -1.123 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 52.79% |